<DOC>
	<DOCNO>NCT02698943</DOCNO>
	<brief_summary>Posterior capsule opacification ( PCO ) glistenings development among primary reason sub-optimal visual capacity follow cataract extraction surgery . Primary objective study evaluate incidence PCO glistenings popular envista MX-60 intraocular lens ( Bausch + Lomb ) random sample cataract patient underwent phacoemulsification least 1 year prior enrollment study</brief_summary>
	<brief_title>Glistenings PCO Evaluation Envista MX60</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Capsule Opacification</mesh_term>
	<criteria>Diagnosis senile cataract stage 3 nuclear opalescence accord Lens Opacities Classification System III ( LOCS3 ) grade scale Endothelial cell count less 1900 , glaucoma , IOPlowering medication , former incisional surgery , former diagnosis corneal disease , diabetes autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>cataract ; intraocular lens ; posterior capsule opacification ; glistening ; ENVISTA</keyword>
</DOC>